ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding culture immunology

2014 Life Sciences Salary Survey
Jyoti Madhusoodanan | Nov 1, 2014 | 6 min read
This year’s data reveal notable variation in compensation for life scientists working in different fields, sectors, and regions of the world.
Funding Briefs
The Scientist Staff | Apr 15, 1990 | 3 min read
Wellcome Welcomes Visiting Professors Universities interested in hosting leading research scientists can tap the Burroughs Wellcome Fund. Each year, Wellcome Visiting Professorships in the Basic Medical Sciences are presented to 21 scientists - three each in physiology, biochemistry/molecular biology, pharmacology, pathology, nutrition, immunology, and cell biology - for visits of two to five days at U.S. institutions. The Wellcome Visiting Professors teach, confer with students and faculty,
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Opinion: Communication Crisis in Research
David Rubenson | Jan 30, 2013 | 4 min read
The problem threatens progress and stems from both a lack of attention to clear discourse and a scientific culture not focused on critical challenges.
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Hughes Biomedical Funding A Mixed Blessing, Some Say
Karen Kreeger | Oct 2, 1994 | 5 min read
And the investment has paid off--as evidenced by, among other things, HHMI researchers' prolific and influential publication record: Last year, for example, nearly one- quarter of the 200 most cited biomedical publications by U.S. scientists were authored by HHMI-affiliated investigators (see story on page 14). But despite the institute'S imposing presence and glowing achievements, some researchers and agency officials contend that
Hughes Biomedical Funding A Mixed Blessing, Some Say
Karen Kreeger | Oct 2, 1994 | 5 min read
And the investment has paid off--as evidenced by, among other things, HHMI researchers' prolific and influential publication record: Last year, for example, nearly one- quarter of the 200 most cited biomedical publications by U.S. scientists were authored by HHMI-affiliated investigators (see story on page 14). But despite the institute'S imposing presence and glowing achievements, some researchers and agency officials contend that
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

Run a Search

ADVERTISEMENT